Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Chen YH, Zhang X, Cheng YF, Chen H, Mo XD, Yan CH, Chen Y, Han W, Sun YQ, Wang Y, Zhang XH, Xu LP, Liu KY, Yang J, Zhang J, Zhang GL, Shi Y, Su YC, Li WQ, Xu L, Song D, Zhang M, Lu P, Huang XJ.
Chen YH, et al. Among authors: shi y.
Cytotherapy. 2020 Dec;22(12):755-761. doi: 10.1016/j.jcyt.2020.08.002. Epub 2020 Aug 26.
Cytotherapy. 2020.
PMID: 32861622